Clinical Trial Update: De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating de-escalation of antiplatelet therapy to assess platelet reactivity and outcomes in high bleeding risk patients with recent acute cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Snippet

Sponsor: Azienda Ospedaliera Universitaria Policlinico "G. Martino" | Conditions: Dual Antiplatelet Therapy, Acute Coronary Syndrome | Phase 3 | Status: UNKNOWN